The founders of Flexion bring together a singular set of competencies in pharmaceutical and business development.

Flexion's founders Michael Clayman, MD (Chief Executive Officer) and Neil Bodick, MD PhD, (Chief Medical Officer) bring a total of 35 years of drug development experience from Eli Lilly, where they separately managed major components of Lilly Research Laboratories. Together at Lilly, they also created Chorus, an early-phase development unit operating with a level of productivity an order of magnitude greater than that of the industry standard.

Their leadership is backed by a strong team of developers and entrepreneurs — a team that is evolving the efficient drug development model started at Lilly.

Learn more about Flexion's senior management, board of directors and investors.

Flexion's founders, Neil Bodick and Michael Clayman

Flexion's founders, Neil Bodick and Michael Clayman.